The World Health Organization (WHO) is likely to approve Russia’s Sputnik V vaccine against coronavirus within two months, Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF) which markets the vaccine, told Reuters.

He said the European Medicines Agency (EMA) which is also reviewing Sputnik V “was provided with all basic existing information, there is no critical remarks for now at all.”